STOCK TITAN

BNP Paribas Asset Management UK reports 0.9% ASP Isotopes (ASPI) stake in 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

BNP Paribas Asset Management UK Ltd has filed an amended Schedule 13G reporting beneficial ownership of 944,326 shares of ASP Isotopes Inc. common stock, representing 0.9% of the outstanding class as of December 31, 2025. The firm reports sole voting and dispositive power over all of these shares and confirms they are held in the ordinary course of business, not to change or influence control of ASP Isotopes.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



BNP Paribas Asset Management UK Ltd
Signature:Timothy Trotter
Name/Title:CCO, US Regulatory Matters
Date:02/09/2026

FAQ

What does BNP Paribas Asset Management UK Ltd report in this ASPI Schedule 13G/A?

BNP Paribas Asset Management UK Ltd reports beneficial ownership of 944,326 ASP Isotopes common shares, equal to 0.9% of the class. The firm holds sole voting and dispositive power over these shares as of December 31, 2025 under an amended Schedule 13G filing.

How much of ASP Isotopes (ASPI) does BNP Paribas Asset Management own?

BNP Paribas Asset Management UK Ltd beneficially owns 944,326 ASP Isotopes common shares, representing 0.9% of the outstanding class. The position is below the 5% threshold and is reported with sole voting and sole dispositive power over all reported shares.

Is BNP Paribas Asset Management seeking control of ASP Isotopes (ASPI)?

The filing states the ASP Isotopes shares were acquired and are held in the ordinary course of business, not to change or influence control. It also notes the holding is not part of any transaction aimed at influencing control, except for specified proxy nomination activities.

What type of SEC filing is this for ASP Isotopes (ASPI)?

This is an amended Schedule 13G/A, a beneficial ownership report used by certain institutional investors. It discloses that BNP Paribas Asset Management UK Ltd holds 0.9% of ASP Isotopes common stock with sole voting and dispositive power over 944,326 shares.

Who signed the ASP Isotopes (ASPI) Schedule 13G/A for BNP Paribas Asset Management?

The Schedule 13G/A was signed by Timothy Trotter, identified as CCO, US Regulatory Matters, on behalf of BNP Paribas Asset Management UK Ltd. The signature certifies the accuracy and completeness of the beneficial ownership information presented in the report.
ASP Isotopes

NASDAQ:ASPI

ASPI Rankings

ASPI Latest News

ASPI Latest SEC Filings

ASPI Stock Data

727.52M
107.41M
22.39%
45.32%
16.81%
Chemicals
Miscellaneous Chemical Products
Link
United States
WASHINGTON